# Radiotherapy * **Definition:** A medical treatment that uses high doses of radiation to kill or damage cancer cells by targeting their DNA, often tailored to the individual patient's needs and may be used in conjunction with other treatments to enhance effectiveness. * **Taxonomy:** Healthcare Topics / Radiotherapy ## News * Selected news on the topic of **Radiotherapy**, for healthcare technology leaders * 8.8K news items are in the system for this topic * Posts have been filtered for tech and healthcare-related keywords | Date | Title | Source | | --- | --- | --- | | 5/22/2025 | [**Neoadjuvant Radiotherapy for Rectal Cancer: A Clinical Trade-Off?**](https://www.medscape.com/viewarticle/neoadjuvant-radiotherapy-rectal-cancer-clinical-trade-2025a1000d07) | [[Medscape]] | | 5/7/2025 | [**Study: One-week breast cancer radiotherapy proven as safe and effective as standard three ...**](https://medicalxpress.com/news/2025-05-week-breast-cancer-radiotherapy-proven.html) | [[MedicalXpress]] | | 5/4/2025 | [**New radiotherapy technique aims to protect the heart during lung cancer treatment**](https://medicalxpress.com/news/2025-05-radiotherapy-technique-aims-heart-lung.html) | [[MedicalXpress]] | | 5/4/2025 | [**Molecular profiling can safely reduce radiation for women with endometrial cancer: Clinical trial results**](https://medicalxpress.com/news/2025-05-molecular-profiling-safely-women-endometrial.html) | [[MedicalXpress]] | | 5/3/2025 | [**Ten year study confirms effectiveness of two-week radiotherapy for prostate cancer**](https://www.news-medical.net/news/20250503/Ten-year-study-confirms-effectiveness-of-two-week-radiotherapy-for-prostate-cancer.aspx) | [[News Medical Net]] | | 4/16/2025 | [**US Radiotherapy Market worth US$2.49 billion by 2030 with 4.6AGR - MarketsandMarkets™**](https://www.prnewswire.com/news-releases/us-radiotherapy-market-worth-us2-49-billion-by-2030-with-4-6-cagr--marketsandmarkets-302430068.html) | [[PR Newswire]] | | 4/15/2025 | [**Four cycles of docetaxel plus cisplatin as neoadjuvant chemotherapy followed by concurrent chemoradiotherapy in stage N2-3 nasopharyngeal carcinoma: phase 3 multicentre randomised controlled trial**](http://www.bmj.com/content/389/bmj-2024-081557.short?rss=1) | [[BMJ]] | | 4/15/2025 | [**Induction chemotherapy for nasopharyngeal carcinoma**](http://www.bmj.com/content/389/bmj.r652.short?rss=1) | [[BMJ]] | | 4/11/2025 | [**US Radiotherapy Market worth US$2.49 billion by 2030 with 4.6AGR - MarketsandMarkets™.**](https://www.globenewswire.com/news-release/2025/04/11/3060070/0/en/US-Radiotherapy-Market-worth-US-2-49-billion-by-2030-with-4-6-CAGR-MarketsandMarkets.html) | [[Globe Newswire]] | | 4/11/2025 | [**US Radiotherapy Market worth US$2.49 billion by 2030 with 4.6AGR - Yahoo Finance**](https://finance.yahoo.com/news/us-radiotherapy-market-worth-us-123000617.html) | [[Yahoo Finance]] | | 3/11/2025 | [**Robotic Radiotherapy Market is expected to generate a revenue of USD 2.95 Billion by 2032, Globally, at 11.6AGR: Verified Market Research®**](https://www.prnewswire.com/news-releases/robotic-radiotherapy-market-is-expected-to-generate-a-revenue-of-usd-2-95-billion-by-2032--globally-at-11-6-cagr-verified-market-research-302398224.html) | [[PR Newswire]] | | 3/4/2025 | [**Robotic Radiotherapy Market Report 2024-2034 - Yahoo Finance**](https://finance.yahoo.com/news/robotic-radiotherapy-market-report-2024-152100813.html) | [[Yahoo Finance]] | | 1/27/2025 | [**Radiotherapy with cetuximab may be superior to radiotherapy alone for patients who undergo surgery for head, neck cancer**](https://medicalxpress.com/news/2025-01-radiotherapy-cetuximab-superior-patients-surgery.html) | [[MedicalXpress]] | | 1/15/2025 | [**Swedish researchers discuss advancements, promise of new radiotherapy techniques**](https://medicalxpress.com/news/2025-01-swedish-discuss-advancements-radiotherapy-techniques.html) | [[MedicalXpress]] | | 12/12/2024 | [**Single-modality endocrine therapy versus radiotherapy after breast-conserving surgery in ...**](https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(24)00661-2/abstract) | [[The Lancet]] | | 12/11/2024 | [**Predictors for radiotherapy success may help some rectal cancer patients avoid surgery**](https://medicalxpress.com/news/2024-12-predictors-radiotherapy-success-rectal-cancer.html) | [[MedicalXpress]] | | 12/11/2024 | [**Radiotherapy Market to Hit USD 9.62 Billion by 2030 with 4.9AGR - PR Newswire**](https://www.prnewswire.com/news-releases/radiotherapy-market-to-hit-usd-9-62-billion-by-2030-with-4-9-cagr--marketsandmarkets-302328686.html) | [[PR Newswire]] | | 11/21/2024 | [**Saudi Arabia Radiotherapy Markets, Competition, Forecast & Opportunities, 2029, Profiles of ...**](https://finance.yahoo.com/news/saudi-arabia-radiotherapy-markets-competition-155700014.html) | [[Yahoo Finance]] | | 10/7/2024 | [**Adding Short-term ADT to High-Dose Radiotherapy Benefits Some Prostate Cancers**](https://www.medscape.com/viewarticle/adding-short-term-adt-high-dose-radiotherapy-benefits-some-2024a1000ic1) | [[Medscape]] | | 9/30/2024 | [**Radiotherapy and theranostics in a changing world - The Lancet Oncology**](https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(24)00499-6/fulltext?rss=yes) | [[The Lancet]] | | 9/30/2024 | [**Radiotherapy and theranostics: a Lancet Oncology Commission**](https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(24)00407-8/abstract?dgcid=tlcom_carousel1_infocusoncology_lanoncradiotherapy24) | [[The Lancet]] | | 8/28/2024 | [**Europe Radiotherapy Patient Positioning Market Set for Robust Growth: Projected to Reach ...**](https://www.morningstar.com/news/accesswire/908841msn/europe-radiotherapy-patient-positioning-market-set-for-robust-growth-projected-to-reach-usd-1961-million-by-2034-future-market-insights-inc) | [[Morningstar]] | | 8/27/2024 | [**Europe Radiotherapy Patient Positioning Market Set for Robust Growth: Projected to Reach USD 196.1 Million by 2034 - Future Market Insights, Inc.**](https://finance.yahoo.com/news/europe-radiotherapy-patient-positioning-market-091000939.html) | [[Yahoo Finance]] | | 8/7/2024 | [**Radiotherapy benefits last a decade, breast cancer study reveals**](https://medicalxpress.com/news/2024-08-radiotherapy-benefits-decade-breast-cancer.html) | [[MedicalXpress]] | | 8/7/2024 | [**Radiotherapy after surgery shown to prevent breast cancer recurrence for up to 10 years**](https://www.news-medical.net/news/20240807/Radiotherapy-after-surgery-shown-to-prevent-breast-cancer-recurrence-for-up-to-10-years.aspx) | [[News Medical Net]] | ## Topic Overview (Some LLM-derived content — please confirm with above primary sources) ### Key Players - **Cancer Research UK**: Provided funding to the Leeds Radiation Research Centre of Excellence to enhance personalized radiotherapy treatments. - **GlyTherix Ltd.**: An Australian company focused on targeted radiotherapy, utilizing lutetium-177 for localized radiation delivery in aggressive cancers. - **Actinium Pharmaceuticals**: Develops targeted radiotherapy solutions, including Antibody Radiation Conjugates for difficult-to-treat cancers. - **Somerset NHS Foundation Trust**: A healthcare provider that launched a new radiotherapy x-ray unit to enhance cancer treatment and reduce patient waiting times. - **GE HealthCare**: A leading company in radiotherapy technology, known for innovations like the Revolution RT system. - **International Agency for Research on Cancer**: An organization that provides data on global cancer cases, emphasizing the need for effective radiotherapy solutions. - **Sun Nuclear**: Leader in radiation oncology quality management, partnering with Varian to enhance treatment delivery. - **Accuray Incorporated**: A company specializing in advanced radiotherapy systems, known for the CyberKnife System used in stereotactic body radiation therapy (SBRT). - **Perceptive Imaging**: A company that has partnered with Radialogica to improve service delivery in radiotherapy treatments. - **IBA Worldwide**: A global leader in particle therapy and advanced radiotherapy solutions. - **UCLA Health Jonsson Comprehensive Cancer Center**: Conducted research demonstrating the benefits of MRI-guided stereotactic body radiotherapy (SBRT) for prostate cancer. - **University of Borås**: Conducts research on digital tools to assist cancer patients and nursing students in managing radiotherapy. - **University of Texas MD Anderson Cancer Center**: A leading cancer research institution that conducted a study on low-dose radiotherapy for stomach lymphoma. - **RefleXion Medical, Inc.**: A company pioneering in the development of SCINTIX therapy, which combines real-time tracking of tumor motion with stereotactic body radiotherapy (SBRT) for enhanced cancer treatment. - **Accuray**: A provider of innovative cancer treatment solutions, including the CyberKnife and TomoTherapy systems. - **Integrated Molecular Solutions (IMS)**: A partner in the development of innovative cancer treatment protocols through adaptive radiotherapy. - **Varian**: A prominent player in the development of radiotherapy systems, including the EthosTM radiation system. - **RaySearch Laboratories AB**: A company specializing in innovative software solutions for cancer treatment, known for its RayStation software used in advanced motion tracking and imaging capabilities. - **Radialogica, LLC**: Joined Perceptive Imaging's supplier network to enhance radiation therapy quality management services. ### Partnerships and Collaborations - **Leeds Radiation Research Centre and Cancer Research UK**: Collaboration to develop kinder and smarter radiotherapy techniques to improve patient outcomes. - **Somerset NHS Foundation Trust and SURE**: Collaborated to develop a new radiotherapy x-ray unit aimed at improving cancer treatment. - **ARPANSA and IAEA**: Collaboration to create a global radiotherapy audit method aimed at improving treatment accuracy and ensuring equitable access to quality radiation treatment. - **Mercy Medical Center and Varian**: Collaboration to implement the TrueBeam system for improved radiotherapy delivery. - **RaySearch Laboratories and Hitachi**: Collaboration to develop the OXRAY radiotherapy machine, enhancing precision in radiation therapy. - **Perceptive Imaging and Radialogica**: This partnership aims to standardize radiation therapy quality management services for global oncology trial sponsors. - **University of Borås and various tech developers**: Research projects aimed at creating digital tools for patient support in radiotherapy. - **Paul Scherrer Institute and University Children's Hospital Zurich**: Collaboration enabling young cancer patients to receive proton therapy. - **Actinium Pharmaceuticals and Eckert & Ziegler**: Entered a supply agreement to support the development of Actinium-225 for targeted radiation therapy. - **Varian and Sun Nuclear**: Alliance to enhance quality assurance offerings and interoperability for radiotherapy solutions. - **GlyTherix and SHINE Technologies**: Entered into a global clinical supply agreement to utilize SHINE's lutetium-177 chloride in clinical trials for aggressive cancers. - **Thera4Care Project**: A European initiative coordinated by Università Cattolica and Fondazione Policlinico Universitario Agostino Gemelli, focusing on developing personalized cancer therapies using advanced imaging and AI. - **USC Norris Comprehensive Cancer Center and ART Health**: Collaboration to open a new treatment center in Newport Beach, enhancing local cancer care. - **Akesis and IMS**: Announced a letter of intent to enhance cancer treatment protocols through the Gemini 360RT systems. - **AngioDynamics and University College London Hospital**: Partnership to evaluate the safety and efficacy of the NanoKnife System for prostate cancer. - **Elekta and Microsoft**: Collaborated to enhance treatment planning through advanced data analytics and AI integration. - **Varian and Ballad Health**: 10-year agreement to enhance oncology treatment services for rural communities. - **Lunit and VIDI Group**: Strategic alliance to deploy Lunit INSIGHT MMG across over 400 sites in France for breast cancer screening. - **Federated Secure Computing Project**: A collaboration among LMU Munich, Fondazione Policlinico Universitario Agostino Gemelli, and Cybernetica to analyze cancer patient data across Europe while ensuring data privacy. ### Innovations, Trends, and Initiatives - **Stereotactic Body Radiation Therapy (SBRT)**: Emerging as a viable alternative to conventional radiotherapy, providing comparable cancer control with significantly reduced treatment time. - **Adaptive Radiotherapy**: Personalized treatment approach for bladder cancer, adjusting dosages based on individual patient needs. - **Response-Adapted Radiation Therapy**: A study indicating that low-dose radiotherapy can effectively control slow-growing stomach lymphoma with minimal toxicity. - **Surface Guided Radiotherapy (SGRT)**: A new technology introduced at Castle Hill Hospital to enhance treatment efficiency and accuracy without permanent tattoo markings. - **Low-Dose Liver Radiotherapy**: A study indicating that low-dose radiotherapy combined with supportive care significantly improves pain management in liver cancer patients. - **AI-Driven Treatment Planning**: Innovations in radiotherapy systems, including IMRT and IGRT, are enhancing treatment precision and expanding applications in cancer treatment. - **Stereotactic Body Radiotherapy (SBRT) and Image-Guided Radiation Therapy (IGRT)**: Gaining popularity for their precision in tumor treatment, contributing to market expansion. - **SCINTIX Therapy**: A new treatment approach that allows for real-time tracking of tumor motion, enhancing the precision of radiation delivery. - **Radiotherapy Technology Advancements**: Innovations such as the Revolution RT system by GE HealthCare are expected to enhance treatment options and stimulate market growth. - **Rays of Hope Programme**: An initiative by the International Atomic Energy Agency to improve access to radiotherapy in low- and middle-income countries. - **AI in Radiotherapy**: AI technologies are being integrated into radiotherapy for auto-contouring, significantly reducing treatment planning time. - **MRI-guided SBRT**: Research indicates that MRI-guided SBRT significantly reduces long-term side effects and improves quality of life for prostate cancer patients. - **Emerging Radiotherapy Technologies**: Advancements in radiosurgery and radiotherapy robotics are expected to drive market growth. - **TOPGEAR Study**: An international clinical trial showing that radiotherapy does not improve survival for operable gastric cancer compared to chemotherapy alone. - **Digital Twins in Healthcare**: Utilizing AI and simulation to enhance decision-making and improve patient outcomes in radiotherapy. - **Lutetium-177 (Lu-177) Therapies**: Increasing demand for targeted radiotherapy solutions, particularly for neuroendocrine and prostate cancers. - **Market Growth Projections**: The market for radiotherapy devices is projected to grow at a CAGR of 7.78% from 2024 to 2030, driven by rising cancer cases and technological advancements. - **Hypofractionation**: A radiation therapy approach that reduces hospital visits by delivering the total radiation dose in fewer parts over a shorter time frame. ### Challenges and Concerns - **Radiation-Induced Cancers**: Concerns about the potential for radiation-induced cancers limit the use of radiotherapy in non-malignant conditions. - **Long-Term Effects of Radiotherapy**: Research highlights the need for understanding the long-term impacts of radiotherapy, especially as advancements in treatment lead to longer patient lifespans. - **Quality of Life Post-Radiotherapy**: Studies indicate that patients receiving radiotherapy for rectal cancer report lower quality of life compared to those who did not receive treatment. - **Implementation of New Treatment Strategies**: Concerns regarding the broader implementation of low-dose radiotherapy due to the study's exclusion of patients with severe symptoms. - **Long-term Risks of Radiotherapy**: Potential for secondary cancers due to radiation exposure, particularly in breast cancer patients who smoke. - **Patient Safety**: Need for improved monitoring of radiation exposure to minimize damage to healthy tissues during cancer treatments. - **Availability of Alternative Therapies**: The presence of alternative cancer treatments could impact the demand for radiotherapy solutions. - **Workforce Shortages**: The urgent need for increased workforce capacity in radiotherapy to meet the growing cancer burden. - **Side Effects of Radiotherapy**: The potential for significant side effects and resistance issues in patients requiring radiotherapy, particularly for meningioma. - **Long-term Effects of Radiotherapy**: Studies show that radiotherapy can create epigenetic memory in skin fibroblasts, leading to long-term skin complications in cancer survivors. - **Long-term Toxicity**: Ongoing challenges related to long-term toxic effects of radiotherapy on healthy tissues. - **Variability in Treatments**: Concerns regarding variability in radiotherapy treatments across investigative sites affecting pharmaceutical efficacy and toxicity evaluations. - **Radiation Necrosis**: High incidence of grade 3 radiation necrosis reported in glioblastoma patients receiving extreme hypofractionation. - **Access Disparities**: Significant disparities in access to radiotherapy worldwide, particularly in low-income regions. - **Risks Associated with Radiation**: Concerns regarding the safety and potential side effects of radiation therapy may hinder patient acceptance and market growth. - **Global Disparities in Access**: Significant inequalities in access to radiotherapy services between high-income and low- to middle-income countries. - **High Initial Costs of Robotic Systems**: The growth of the robotic radiotherapy market is hindered by high initial costs and stringent regulatory approvals. - **Equipment and Staff Shortages**: Research indicates that cancer treatment in former Soviet Union countries is hindered by insufficient resources. ## Related Topics [[Radiation Oncology]]